Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) Acute Coronary Syndromes Critical Pathway Toolkit

Critical Pathways in Cardiology

Volumn 2, Issue 3, 2003, Pages 153-177

  Cannon, Christopher P ^a   Braunwald, Eugene ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Acute coronary syndromes; Anticoagulants; Antiplatelet agents; Antithrombins; Cardiac catheterization; Critical pathways; Myocardial infarction; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; OXYGEN; POTASSIUM CHLORIDE;

ALGORITHM; CLINICAL PATHWAY; ELECTROCARDIOGRAPHY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY DIAGNOSIS; LONG TERM CARE; MEDICAL SOCIETY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING;

EID: 0142197094     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hpc.0000085366.42909.60     Document Type: Review

References (11)

1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002;106:1893-1900.
2. Scirica BM, Cannon CP, Gibson CM, et al. Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST-elevation myocardial infarction in the TIMI III (1990-93) and the GUARANTEE (1995-96) registries. Crit Path Cardiol. 2002;1:151-160.
3. Mehta RH, Montoye CK, Gallogly M, et al. Improving quality of care of acute myocardial infarction: the Guideline Applied in Practice (GAP) initiative in southeast Michigan. JAMA. 2002;287:1269-1276.
4. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
5. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-533.
6. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420.
7. Lamy A, Chrolavicius S, Gafni A, et al. The cost-effectiveness of the use of clopidogrel in acute coronary syndromes based upon the CURE study. Circulation. 2002;106 (suppl II):II-758.
8. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999;354:708-715.
9. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887.
10. Peters RJG, Zed, F., Lewis BS, Fox, K. A. A., Yusuf S, the CURE Investigators. Aspirin dose and bleeding events in the CURE study. Eur Heart J. 2002;4 (suppl):510.
11. Cannon CP, Ornato JP. How to develop a critical pathway: the ACS ACTION program. Crit Path Cardiol. 2002;1:53-60.